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explored). We evaluated the ADN ultrastructural alterations caused by long term experi-
mental diabetes and the effects of insulin treatment. Wistar rats (N¼14) received a single
intravenous injection of streptozotocin (40 mg/kg) 12 weeks before the experiment. Control
animals (N¼9) received vehicle (citrate buffer). Insulin treated animals (N¼8) received a
single subcutaneous injection of insulin daily. Under pentobarbital anesthesia the ADNs
were isolated and had their spontaneous activity recorded. Afterwards, proximal and distal
segments of the nerves were prepared for transmission electron microscopy study.
Morphometry of the unmyelinated fibers was carried out with the aid of computer
software. ADN of the diabetic animals showed axonal atrophy for myelinated fibers, with
more pronounced alterations of the myelin sheath, such as myelin infolding and out
folding, presence of myelin balls and very thin myelin sheath in relation to the axonal size,
particularly for the small myelinated fibers becoming evident. No differences were
observed in myelinated fiber number and their density, as well as on the fascicular area.
Unmyelinated fiber number was significantly larger in the diabetic group while fiber
diameter was significantly smaller compared to control. This result suggests axonal
atrophy or, if associated to the larger number of fibers present in this group, could indicate
fiber sprouting. These alterations were more evident in the distal segments of the nerves
and were moderated by insulin treatment.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.54
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Since 1960s, considerable research has been done on diabetic
neuropathy, but a reliable description of the nerve alterations
has not yet been presented. It has been clearly established,
however, that an axonal loss occurs in the peripheral nerves
and their trunks (Chopra et al., 1969; Greenbaum et al., 1964;
Thomas, 1967), affecting both myelinated and unmyelinated
axons (Behse et al., 1977), while being more evident in the
distal segments of the nerve (Knopp and Rajabally, 2012).
Dysfunction of the baroreflex control of arterial pressure
and heart rate have been thoroughly described, not only in
diabetic patients (Low et al., 1975; Wang et al., 2012), but also
in experimental models of diabetes (Fazan et al., 1997a,
1999a; McDowell et al., 1994a,b). Most reports on decreased
baroreflex sensitivity in diabetic patients attribute this out-
come to the autonomic neuropathy involving the efferent
arm (vagus nerve and sympathetic nerves). The afferent arm
of the baroreflex, i.e. the arterial baroreceptors (carotid sinus
and aortic depressor nerves) has received less attention. The
first detailed description of the morphological aspects and
morphometric characteristics of the aortic depressor nerve
(ADN) in rats was published in 1997 (Fazan et al., 1997b) but
until now, the morphological ultrastructural involvement of
the ADN in diabetes was not yet investigated.
It is well documented that the metabolic and morphologi-
cal alterations due to diabetes can be prevented or even
reverted by means of the insulin treatment (Jakobsen, 1979;
Rodrigues Filho and Fazan, 2006) but this notion is still
controversial. Recently, Fazan et al. (Fazan et al., 2009)
demonstrated that endoneural blood vessels are susceptible
to insulin treatment, with important ultrastructural altera-
tions of the unmyelinated fibers. Also, a remarkable number
of fibers undergoing Wallerian degeneration was described in
nerves from diabetic animals treated with insulin (Sharma
et al., 1985, Westfall et al., 1983).
The goals of this study were to assess the effect of long
term experimental diabetes on the morphological aspects
and morphometric parameters of the ADN in rats, at the
ultrastructural level, as well as to investigate whether insulin
treatment had a protective effect on ADN alterations caused
by experimentally induced diabetes.Table 1 – Body weight and blood glucose level on the 3rd day
experimental day (12 weeks after injection), together with aver
experimental day. Data are expressed as mean7standard err
Body weight B
Control—3 days 199710
STZ—3 days 19979 5
STZþIns—3 days 19578 5
Control—12 weeks 535750c
STZ—12 weeks 233755ac 4
STZþIns—12 weeks 616746abc 1
STZ¼diabetic group and STZþIns¼Diabetic group treated with insulin.
a Significant difference compared to control group at the same experim
b Significant difference compared to STZ group at the same experiment
c Significant difference compared to the same group at 3 days.2. Results
Body weight and blood glucose levels obtained on the 3rd day
after injections and on the experimental day, as well as the
mean arterial pressure (MAP) and heart rate (HR) recorded on
the experimental day are shown in Table 1. No differences
were detected on body weight among groups at the beginning
of the experiments and all three groups gained weight
significantly during the 12-week period. Nevertheless, dia-
betic rats gained significantly less weight as compared to
control and insulin treated animals. As expected, blood
glucose level was significantly higher in both diabetic groups
three days after STZ injection but it was corrected with
insulin treatment. MAP was significantly reduced in both
diabetic groups while the HR was reduced in the diabetic
group as compared with the insulin treated group.
2.1. Morphology
The ADN of control animals showed normal morphological
characteristics as previously described (Fazan et al., 1997b,
2001) in normotensive animals (Fig. 1).
The ADN of diabetic animals displayed axonal atrophy for
the myelinated fibers, but the alterations were more evident
on the myelin sheath, including infolding and out folding of
the myelin sheath, presence of balls of myelin, myelin loops
and splitting, and very thin myelin sheaths in relation to the
axon size, particularly for small myelinated fibers. Several
nerves presented myelinated axons much larger than would
be expected, with some having almost no myelin sheath
(Fig. 1). The unmyelinated fibers were more conserved in this
experimental group in terms of morphology but clusters of
very small unmyelinated fibers were present in all nerves of
this group (Fig. 1). Some unmyelinated fibers also showed
clear signs of axonal atrophy. Interestingly, the endoneural
vessels, when present, had their morphology preserved
(Fig. 1).
The ADN of the insulin treated group showed the same
alterations described for the diabetic group, to a less extent.
It was very common the presence of small myelinated fibers
with loose or very thin myelin sheaths, suggesting remyeli-
nation (Fig. 1). Clusters of small unmyelinated fibers wereafter streptozotocin (STZ) or vehicle injection, and on the
age mean arterial pressure (MAP) and heart rate (HR) on the
or of mean (SEM).
lood glucose MAP HR
8576
19735a
25737a
73710c 140718 338721
69790a 111710a 299722a
32713c 11577a 327712b
ental time.
al time.
Fig. 1 – Transmission electron microscopy images of the
aortic depressor nerves (ADN) of control (A and B),
diabetic (C–F) and diabetic treated with insulin (G and H)
animals. Figure A and B show normal characteristics of the
ADN fascicle (A) and endoneural space (B). Nerves from
diabetic animals showed several alterations like the pre-
sence of very large axons with normal myelin sheaths
(arrows in C) or with the myelin sheath completely
destroyed (asterisk in C and D and arrows in D). Also, very
small unmyelinated fibers were present (arrows in E and F),
while endoneural blood vessels (V) were preserved. Insulin
treated animals showed myelin fibers with very thin
sheaths (arrows in G) and small myelinated fibers almost
completely destroyed (arrows in H). Very small unmyeli-
nated axons were also present in this group and thickening
of the Schwann cell basement membrane was identified
(arrow heads in H).
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basal membrane of these fibers was noted (Fig. 1). The
endoneural vessels, when present, were also preserved.
2.2. Morphometry
Fascicular area, myelinated fiber number and density,
Schwann cell nuclei number and density and the ratio
between unmyelinated/myelinated fiber number for proximal
and distal segments of the ADN from all experimental groups
are shown in Table 2. No differences were observed between
proximal and distal segments in any of the experimental
groups. No differences were observed on the fascicular area
between groups for both segments. A tendency (p¼0.07)
towards a reduction of the myelinated fibers number from
controls to the insulin treated animals was observed.
A tendency (p¼0.09) towards an increase in the Schwann
cell nuclei density from controls to diabetic animals was also
observed. The unmyelinated/myelinated fiber ratio was two-
fold larger in both diabetic groups compared to controls, but
reached significant levels only on the distal segment.
The unmyelinated fiber number, density, percentage of
occupancy and diameter, for proximal and distal segments
of the ADN from all experimental groups are shown in Fig. 2.
The unmyelinated fiber number was higher in the diabetic
group when compared with the other two groups, attaining
significance on the distal segment. Their density was sig-
nificantly larger in the diabetic group in both proximal and
distal segments and also larger in the insulin treated group in
the distal segment when compared to controls. The unmye-
linated fiber percentage of occupancy was significantly larger
in the diabetic group in both proximal and distal segments
when compared to controls. Interestingly, the unmyelinated
fiber diameter was smaller in the diabetic group when
compared with the control, attaining significance on the
distal segment.
Unmyelinated fiber size distributions for proximal and
distal segments of the ADN from all experimental groups
are represented in Fig. 3. Unmyelinated fiber diameter ranged
between 1.0 and 1.6 mm, distributed unimodally, with peak of
frequency at 0.5 mm in all experimental groups. No differ-
ences were observed between segments in the three experi-
mental groups. Nevertheless, on the proximal segments, a
shift to the left (increase on the percentage of the small
fibers) was observed on the diabetic group, while the dis-
tribution of the insulin treated group was similar to the
control. On the distal segments, the shift to the left was
more evident and was present on both diabetic groups, as
compared to the control.3. Discussion
The STZ-diabetes model was widely used to investigate
experimental diabetic peripheral neuropathies (Jakobsen
and Lundbaek, 1976; Jakobsen, 1979; McCallum et al., 1986,
Sharma et al., 1977, 1985; Sugimura et al., 1980), but
few studies have performed a detailed assessment of unmye-
linated fibers morphology and morphometry in this
animal model. Therefore, the present study provides the first
Table 2 – Morphometric parameters of the proximal and distal segments of the aortic depressor nerve (AND) in control,
diabetic (STZ) and diabetic treated with insulin (STZþIns) groups. Data are expressed as mean7standard error of
mean (SEM).
Control STZ STZþIns
Proximal Segments
Fascicular area (mm2) 16737191 12447139 12927213
Myelinated fiber number 8176 8277 70711
Myelinated fiber density (fiber/mm2) 5102574760 7032374916ab 5367773021
Schwann cell nuclei number 1071 1171 1072
Schwann cell nuclei density (nucleus/mm2) 59867349 89517960 755871239
Unmyelinated/myelinated fiber ratio 271 571 471
Distal Segments
Fascicular area (mm2) 15937185 13797141 13897322
Myelinated fiber number 7779 8576 73712
Myelinated fiber density (fiber/mm2) 4876672547 6555974593 5942177792
Schwann cell nuclei number 1071 1271 971
Schwann cell nuclei density (nucleus/mm2) 68807944 89847660 754371310
Unmyelinated/myelinated fiber ratio 271 471a 471
a Significant difference compared to control group.
b Significant difference compared to STZþIns group.
Fig. 2 – Morphometric parameters of the unmyelinated fibers of the proximal (upper panels) and distal (lower panels)
segments of the aortic depressor nerve (ADN) in control, diabetic (STZ) and diabetic treated with insulin (STZþIns) animals.
No differences between proximal and distal segments were observed in any of the groups studied.  indicates significant
difference compared to control group.
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this model. Moreover, this study adds useful information for
further investigations on the ultrastructural basis of the
baroreflex function in diabetes. The most striking findings
in diabetic animals was that the unmyelinated fibers of the
ADN increased in number but reduced in size. These altera-
tions were more severe in the distal segments of the nerves
and conventional insulin treatment was able, to a certain
extent, to delay, but not completely prevent this injury.
The reduced axonal size suggests atrophy, but associated
with the larger number of fibers indicates fiber sprouting.
This finding is also in line with the larger density of Schwann
cell nuclei (number/mm2) observed in the diabetic group. It iswell known that Schwann cells are important in the regen-
erative process following nerve injury. Nerves experiencing
regeneration will have a larger number of Schwann cells due
to their augmented duplication rate (Thomas, 1948). Our
results suggest that diabetic nerves might have been under
regeneration and an important further step of this work will
be to determine the time frame of nerve involvement and the
beginning of the regenerative process.
The smaller diameter of the unmyelinated fibers in diabetic
animals might reflect directly on their function. Measure-
ment of the conduction velocity of ADN unmyelinated fibers
indicated a speed of 0.5–2 m/s (Brown et al., 1976, Fan and
Andresen, 1998). In the present study, we did not measure the
Fig. 3 – Unmyelinated fiber size distributions of the prox-
imal (upper panel) and distal (lower panel) segments of the
aortic depressor nerve (ADN) in control, diabetic (STZ) and
diabetic treated with insulin (STZþIns) animals. Unmyeli-
nated fiber distributions are unimodal with peak at 0.5 lm.
Note, on the proximal segments, a tendency towards a
smaller fiber size on the diabetic group (clear circles), not
evident on the treated group (triangle). On the distal seg-
ments, there is a clear and important shift to the smaller
fibers size in both diabetic groups.
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scaling factor of Gasser (Gasser, 1955) for calculating the
conduction velocity of unmyelinated fibers in meters
per second (1.7 times the axonal diameter), we calculated
that 68% of the unmyelinated fibers in control animals
conduct at 0.7–1.4 m/s, whereas 68% of those from diabetic
animals conduct at 0.5–1.0 m/s. This data suggests that the
unmyelinated fibers from diabetic animals might be conduct-
ing baroreceptor impulses to the central nervous system
more slowly than in control rats.
The decreased MAP in diabetic rats, as described in the
present study and others (Carmo et al., 2007, 2011; Fazan
et al., 1997a, 1999a), may be the result of a decrease in cardiac
output due to the hypovolemia caused by osmotic diuresis
(Kohler et al., 1980), or myocardial dysfunction due to
a reduced myocardial contractility (Hebden et al., 1986).A decrease of peripheral resistance might also play a role
reducing MAP (Low et al., 1975). However, we cannot exclude
the possibility that the changes we observed in MAP in
diabetic rats could be due to poor baroreceptor information
reaching the central nervous system through an impaired
ADN. The unmyelinated fibers in the ADN contribute to the
tonic control of blood pressure (Thore´n et al., 1977). Since
the unmyelinated fibers are the predominant fiber type in the
ADN, their effect is particularly important when the blood
pressure is increased. If these fibers are not conducting
properly, fluctuation of the blood pressure may occur, and a
deficit in responding to an increase in blood pressure would
be expected.
The phrenic nerve neuropathy was recently investigated in
the STZ-induced model (Fazan et al., 2009). The authors
showed a tendency towards an increase of the unmyelinated
fibers number and density, similar to our results. Never-
theless, they showed a very important alteration on the
endoneural blood vessels, severe enough to cause endoneural
ischemia, suggesting that the small fiber alterations could be
due to a poor vascularization of the endoneural space (Fazan
et al., 2009; Parry and Brown, 1982). In the present study, the
endoneural blood vessels showed normal morphological
features, pointing to the fact that the unmyelinated fiber
diabetic neuropathy is not only directly related to the lesions
of the blood vessels, but also responsive to the high blood
glucose level itself. It is important to mention that the
neuropathology of the small fiber diabetic neuropathy is not
yet completely elucidated and the ADN is very small in size
being a single endoneural blood vessel present in only about
50% of them (Fazan et al., 1997b).
Alterations of the morphology and morphometric para-
meters of the myelinated fibers in the STZ-diabetes model
were investigated by light microscopy, not only on the ADN
(Fazan et al., 2006) but also on other nerves (Behse et al., 1977;
Ochodnicka et al., 1995; Rodrigues Filho and Fazan, 2006;
Thomas, 1967). Most of the reports agree on the presence of
axonal atrophy on the myelinated fibers in this diabetic
model. The present study adds to the literature that not only
the axonal atrophy previously described is present, but also
the Schwann cells are injured, because several degrees of
myelin lesions were present in both diabetic groups.
It was demonstrated that a daily subcutaneous insulin
injection for two months normalized the body weight of
STZ-induced diabetic rats, but did not correct the myelinated
fiber size (Sharma et al., 1985). In diabetic rats, conventional
insulin treatment for 16 weeks corrected the axonal area,
although the total fiber area was not normalized, suggesting
the possibility that the Schwann cell responds to insulin
treatment more slowly (Ochodnicka et al., 1995). These
results are similar to our observations that the density of
Schwann cell nuclei in the insulin-treated group was greater
than in the control group, but smaller than in the diabetic
group.4. Conclusion
Long term experimental diabetes caused important morpho-
logical and morphometric alterations in the aortic depressor
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 9 7 – 2 0 3202nerve of Wistar rats for both myelinated and unmyelinated
fibers. These alterations were more severe on the distal
segments, exhibiting a ‘‘dying back’’ type neuropathy. These
alterations were not dependent on the endoneural blood
vessels lesions and treatment with insulin delayed, but did
not stop or correct the observed lesions. Therefore, our
results indicate that the baroreflex impairment described in
the literature for chronic diabetic patients or experimental
animals is due not only to efferent neuropathy as widely
accepted, but also to an afferent diabetic neuropathy.5. Experimental procedures
5.1. Animals
Experiments were performed upon male Wistar rats, from
the animal care facility of the Campus of Ribeir ~ao Preto
(University of S ~ao Paulo), weighing 180–200 g at the beginning
of the experiments, housed in plastic cages with free access
to tap water and rat chow throughout the experiment.
Diabetic rats received a single injection of streptozotocin
(STZ) (40 mg/kg, Sigma Chemical Co., St. Louis, MO, USA) 12
weeks (N¼14) into the penile vein before the experiments.
Control animals (N¼9) received vehicle (citrate buffer, pH 5.2)
and confirmed diabetic animals (N¼8) received a single
subcutaneous injection of insulin on a daily basis. Under
pentobarbital anesthesia, the ADNs were isolated and had
their spontaneous activity recorded together with the pulsa-
tile arterial pressure (Fazan et al., 1999b). Proximal and distal
segments of the left ADN were prepared for transmission
electron microscopy as reported previously (Fazan et al.,
1997b, 2001; Sato et al., 2006). Morphometry was carried out
with the aid of computer software.
Nonfasting blood glucose (mg/dL) was determined by
means of a glucose analyzer (Beckman Instruments Inc., Brea,
CA, USA) on the third day after STZ injection and at the time
of the experiments. All experimental procedures adhered to
the Guide for the Care and Use of Laboratory Animals
prepared by the National Academy of Sciences and published
by the National Institutes of Health (Copyright&1996 by the
National Academy of Sciences), and were approved by the
Institutional Ethics Committee for Animal Research (CETEA–-
Comiteˆ de Etica em Experimentac ~ao Animal, protocol number
220/2007). A conscious effort was done to minimize the
number of animals used.5.2. Insulin treatment
Animals with glucose levels higher than 350 mg/dL, observed
on the 3rd day after the STZ injection, were considered
diabetic and included in the study. Treated animals received
a subcutaneous injection of 9 IU/kg of NPH (highly purified
mixed) insulin (Biolin U-100, Biobra´s) in the evening, always
at the beginning of the dark cycle, from the 3rd day after STZ
injection throughout the experiment. The animals were
weighed every 3 days and, when necessary, the insulin dose
was adjusted.5.3. Light microscopy
All samples were processed at together to assure that the
alterations observed were not due to artifacts introduced by
the histological process. The light microscopy study was
performed to validate the quality of the histological prepara-
tion of the nerves. Only those with good histological pre-
servation were used. The fascicle images were collected using
a digital camera (Axiocam MR5, Carl Zeiss) connected to an
IBM PC. With the aid of KS 400 software (Kontron 2.0, Eching
Bei Muchen, Germany), the total number of myelinated fibers
present in each fascicle was identified by visual inspection
and counted. The area and diameter of each fascicle (exclud-
ing the perineurium) were measured, and the myelinated
fiber density was calculated.
5.4. Transmission electron microscopy
For the ultrastructural studies, thin transverse sections were
mounted on Formvar coated 21 slot grids, stained with lead
citrate and uranyl acetate, and observed with a JEM-1230
transmission electron microscope (JEOL-USA, Inc., Peabody,
MA, USA) equippedwith a digital camera. The investigator was
blinded to group identity throughout the morphometric pro-
cess. Sample morphometry was not used and 100% of the
fascicle area was studied. Using the image analysis software,
the total number of the unmyelinated fibers was counted, and
their diameter measured. The density of the unmyelinated
fiber was calculated and the ratio between unmyelinated/
myelinated fibers was determined. Also, the percentage of
the fascicular area occupied by the unmyelinated fibers
(percentage of occupancy) was calculated. A histogram of the
unmyelinated fiber population was constructed and separated
into class intervals increasing by 0.1 mm. Data are presented as
mean7standard error of mean (SEM).
5.5. Statistical analysis
The Kolmogorov–Smirnov test was applied to verify the
normal distribution for weight, biochemical and morpho-
metric data, using the Sigma Stat software, version 3.01
(Jandel Scientific), followed by the Levene test of medians
for variance equivalence.
Body weight, mean arterial pressure (MAP) and heart rate
(HR) data were compared between the 3rd day of injection and
the experimental day by the paired Student’s t-test and among
groups by the one-way ANOVA, followed by Holm-Sidak post-
hoc test, provided that these data showed normal distribution.
Blood glucose data did not show normal distribution and were
compared between the 3rd day of injection and the experi-
mental day by the non-parametric test of Wilcoxon for paired
samples, and among groups by the analysis of variance on
Ranks, followed by Dunn’s post-hoc test.
Morphometric data that passed the normality and variance
equivalence tests were compared by paired Student’s t-test
(between the proximal and distal segments) and one way
ANOVA followed by a Holm-Sidak post-hoc test (for segments
between groups). Otherwise, proximal and distal segments
were compared using the non-parametric test of Wilcoxon
for paired samples, while groups were compared by the
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 9 7 – 2 0 3 203analysis of variance on ranks, followed by Dunn’s post-hoc
test.
Differences were considered significant when po0.05.Acknowledgments
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